Evidence map›Paper›PMID 38089023›Full record

ArticleFrontiers in public health2023

Epidemiology of vancomycin-resistant enterococci in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data.

Jens Thomsen, Najiba M Abdulrazzak, Hussain AlRand, UAE AMR Surveillance Consortium, Godfred Antony Menezes, Carole A Moubareck, Dean B Everett, Abiola Senok, Andreas Podbielski

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Jens ThomsenDepartment of Environmental and Occupational Health and Safety, Abu Dhabi Public Health Center, Abu Dhabi, United Arab Emirates.
Najiba M AbdulrazzakAl Kuwait Hospital Dubai, Emirates Health Services Establishment (EHS), Dubai, United Arab Emirates.
Hussain AlRandPublic Health Sector, Ministry of Health and Prevention, Dubai, United Arab Emirates.
UAE AMR Surveillance Consortium
Godfred Antony MenezesDepartment of Medical Microbiology and Immunology, Ras Al Khaimah (RAK) Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
Carole A MoubareckCollege of Natural and Health Sciences, Zayed University, Dubai, United Arab Emirates.
Dean B EverettDepartment of Pathology and Infectious Diseases, Khalifa University, Abu Dhabi, United Arab Emirates.
Abiola SenokCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Andreas PodbielskiInstitute of Medical Microbiology, Virology and Hygiene, University Medicine, Rostock, Germany.
Khalifa University of Science and Technology · AEDubai Hospital · AEInstitute of Medical Microbiology and Hygiene · DEMinistry of Health · AEMohammed Bin Rashid University of Medicine and Health Sciences · AERas al-Khaimah Medical and Health Sciences University · AEZayed University · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Enterococci are usually low pathogenic, but can cause invasive disease under certain circumstances, including urinary tract infections, bacteremia, endocarditis, and meningitis, and are associated with peritonitis and intra-abdominal abscesses. Increasing resistance of enterococci to glycopeptides and fluoroquinolones, and high-level resistance to aminoglycosides is a concern. National antimicrobial resistance (AMR) surveillance data for enterococci from the Middle East and North Africa (MENA) and the Gulf region is scarce. Methods: A retrospective 12-year analysis of Results: Discussion: Published data on

Indexed as

Gram-Positive Bacterial InfectionsVancomycin-Resistant EnterococciAnti-Bacterial AgentsFluoroquinolonesGlycopeptidesHumansMicrobial Sensitivity TestsRetrospective StudiesUnited Arab EmiratesVancomycin ResistanceAnti-Bacterial AgentsFluoroquinolonesGlycopeptidesantimicrobial resistance (AMR)surveillanceUnited Arab Emirates (UAE)vancomycinvancomycin-resistant enterococci (VRE)

Identifiers

PMID38089023
PMCPMC10715431
OpenAlexW4389053831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.